Operating an unlicensed private intraoperative high-dose-rate (HDR) brachytherapy unit in Nigeria carries severe criminal sanctions, immediate facility sealing, confiscation of radioactive sources, and personal director liability under the Nuclear Safety and Radiation Protection Act, Cap N142, Laws of the Federation of Nigeria 2004. The Nigerian Nuclear Regulatory Authority (NNRA) possesses statutory authority under Sections 4, 43, and 44 of the Act to shut down non-compliant radiotherapy centers, seize ionizing radiation equipment, impose heavy administrative fines, and initiate criminal prosecution against hospital directors and clinical personnel.
Intraoperative high-dose-rate brachytherapy utilizes potent sealed radioactive sources, typically Iridium-192 or Cobalt-60, placed directly inside or adjacent to surgical tumor beds during operative oncology procedures. Due to the catastrophic risks of accidental radiation overexposure, tissue necrosis, radiation poisoning, and illicit nuclear diversion, the Nigerian legal framework strictly prohibits the procurement, importation, installation, or clinical commissioning of any ionizing radiation equipment without explicit written authorization from the NNRA.
The Nuclear Safety and Radiation Protection Act establishes clear statutory offences and severe punitive measures for unauthorised radiation practices:
- Criminal Penalties for Unlicensed Operation: Under Section 43 of the Act, any person or corporate entity operating a radiation facility without a valid licence commits a federal offence punishable upon conviction by substantial fines, imprisonment for a term of up to five years, or both.
- Personal Director Liability: Section 45 explicitly pierces the corporate veil. Where an offence under the Act is committed by a body corporate, every director, chief executive officer, radiation oncologist, and corporate secretary is deemed personally guilty of the offence unless they establish that the violation took place without their knowledge and that they exercised all due diligence to prevent its commission.
- Radioactive Source Confiscation: NNRA enforcement officers have statutory powers to enter medical facilities without prior notice, seize uncertified radioactive isotopes, and transfer them under military or armed police escort to the National Radioactive Waste Management Centre at the expense of the defaulting healthcare facility.
- Immediate Facility Sealing: The NNRA possesses summary administrative authority to seal the affected operating theater, radiotherapy bunker, and adjacent clinical wards, halting all commercial hospital activities until total regulatory compliance is proven.
Under the Companies and Allied Matters Act (CAMA) 2020, running an unlicensed ionizing oncology unit triggers major corporate governance liabilities:
- Director Disqualification: Under Section 280 and Section 284 of CAMA 2020, any director convicted of criminal infractions relating to public safety, environmental endangerment, or corporate fraud faces mandatory disqualification from serving on the board of any Nigerian company for up to ten years.
- Ultra Vires Business Conduct: Operating specialized nuclear medical machinery without statutory regulatory clearance exceeds the lawful corporate capacity of the company, exposing management to derivative shareholder actions under Section 343 of CAMA 2020.
- Compulsory Corporate Winding Up: The Federal High Court may order the winding up of the corporate hospital entity under Section 571 of CAMA 2020 on just and equitable grounds if the company conducts its business in an unlawful, hazardous, or fraudulent manner.
Medical directors and clinical specialists also face swift disciplinary actions from other apex healthcare regulators:
- Medical and Dental Council of Nigeria (MDCN): Radiation oncologists and medical physicists participating in uncertified brachytherapy sessions face immediate suspension and permanent revocation of their medical practising licences for infamous conduct in a professional respect.
- State Health Regulatory Agencies: State health regulatory bodies, such as the Health Facility Monitoring and Accreditation Agency (HEFAMAA) in Lagos State, will revoke the private hospital operating licence, compounding the federal enforcement action.
To operate an intraoperative HDR brachytherapy unit lawfully in Nigeria, a healthcare enterprise must complete a five-stage authorization pathway with the NNRA:
- Site and Design Evaluation: Submit detailed architectural bunker plans, radiation shielding calculations, and facility blueprints to the NNRA for technical safety evaluation.
- Importation and Transport Authorisation: Secure an official NNRA permit before purchasing, importing, or transporting radioactive isotopes through Nigerian ports and highways.
- Staffing Accreditation: Employ fully certified medical physicists, radiation oncologists, and an NNRA-certified Radiation Safety Officer (RSO) with verified dosimetry training.
- Pre-Commissioning Inspection: Permit NNRA safety inspectors to conduct comprehensive radiation surveys, interlock testing, emergency retraction trials, and radiation area monitoring.
- Operational Licencing: Obtain the official NNRA Operating Licence, renewable annually following physical surveillance audits, calibration logs inspection, and radioactive waste disposal verification.
Healthcare promoters must recognize that clinical cancer therapy using sealed radioactive isotopes is heavily policed under Nigerian and international nuclear safety conventions. Compliance with NNRA guidelines is not merely a technical guideline but a vital statutory prerequisite that shields directors from criminal indictment, protects healthcare professionals, and guarantees patient safety.



